NEXGEL, INC. Payments to Acquire Marketable Securities
NEXGEL, INC. (NXGL) reported Payments to Acquire Marketable Securities of $7.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2024-04-10.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireMarketableSecurities · last filed 2024-04-10
- NEXGEL, INC. payments to acquire marketable securities for the quarter ending 2022-12-31 was $19.00K.
- NEXGEL, INC. payments to acquire marketable securities for the quarter ending 2022-09-30 was $1.61M.
- NEXGEL, INC. payments to acquire marketable securities for fiscal 2022 was $7.00M.
| Period end | Payments to Acquire Marketable Securities 3 month | Payments to Acquire Marketable Securities 6 month | Payments to Acquire Marketable Securities 9 month | Payments to Acquire Marketable Securities 12 month |
|---|---|---|---|---|
| 2022-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $1.63M derived: sum of 2 quarters · filed 2024-04-10 | $7.00M 10-K · filed 2024-04-10 | |
| 2022-09-30 | $1.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $6.98M 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | $5.37M 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |